Matrix Metalloproteinase-2 and -9 Levels in Obese Patients

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 4, 2008, Pages 219-224

  Derosa, G ^a   Ferrari, I ^a   D'Angelo, A ^a   Tinelli, C ^b   Salvadeo, S A T ^a   Ciccarelli, L ^c   Piccinni, M N ^d   Gravina, A ^a   Ramondetti, F ^a   Maffioli, P ^a   Cicero, A F G ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c RSA Don Leone Porta   (Italy)

^d Fondazione Ospedale Della Caritá   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Extracellular Matrix; Metalloproteinases; Obesity

Indexed keywords

CHOLESTEROL; GELATINASE A; GELATINASE B; GLUCOSE; INSULIN; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADIPOGENESIS; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENZYME METABOLISM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN RESISTANCE; ITALY; LIPIDS; LIPOPROTEIN(A); MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OBESITY;

EID: 48549083755     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802228815     Document Type: Article

References (41)

1. Ailhaud, G., Grimaldi, P. and Ne'grel, R. (1992) Cellular and molecular aspects of adipose tissue development. 12, pp. 207-233.
2. American Diabetes Association (2001) Screening for diabetes (Position Statement). 24, pp. S21-S24.
3. Bouloumie, A., Sengenes, C., Portolan, G., Galitzky, J. and Lafontan, M. (2001) Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation. 50, pp. 2080-2086.
4. Brown, L. M., Fox, H. L., Hazen, S. A., LaNoue, K. F., Rannels, S. R. and Lynch, C. J. (1997) Role of the matrix in MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. 272, pp. C937-C949.
5. Cicero, A. F., Derosa, G., Manca, M., Bove, M., Borghi, C. and Gaddi, A. V. (2007) Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. 14, pp. 193-198.
6. Crandall, D. L., Hausman, G. J. and Kral, J. G. (1997) A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives. 4, pp. 211-232.
7. Death, A. K., Fisher, E. J., McGrath, K. C. and Yue, D. K. (2003) High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes. 168, pp. 263-269.
8. Derosa, G., Avanzini, M. A., Geroldi, D., Fogari, R., Lorini, R., De Silvestri, A., Tinelli, C., Rondini, G. and d'Annunzio, G. (2004) Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes. 27, pp. 273-274.
9. Derosa, G., Avanzini, M. A., Geroldi, D., Fogari, R., Lorini, R., De Silvestri, A., Tinelli, C., Rondini, G. and d'Annunzio, G. (2005) Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. 70, pp. 119-125.
10. Derosa, G., D'Angelo, A., Ciccarelli, L., Piccinni, M. N., Pricolo, F., Salvadeo, S., Montagna, L., Gravina, A., Ferrari, I., Galli, S., Paniga, S., Tinelli, C. and Cicero, A. F. (2006) Matrix Metalloproteinase-2, -9 and tissue inhibitor metalloproteinase-1 in patients with hypertension. 13, pp. 227-231.
11. Derosa, G., D'Angelo, A., Scalise, F., Avanzini, M. A., Tinelli, C., Peros, E., Fogari, E. and Cicero, A. F. (2007) Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary sindrome. 22, pp. 361-370.
12. Derosa, G., D'Angelo, A., Tinelli, C., Devangelio, E., Consoli, A., Miccoli, R., Penno, G., Del Prato, S., Paniga, S. and Cicero, A. F. (2007) Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 33, pp. 129-134.
13. Derosa, G., Cicero, A. F., Scalise, F., Avanzini, M. A., Tinelli, C., Peros, E., Fogari, E. and D'Angelo, A. (2007) Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months. 14, pp. 175-183.
14. Derosa, G., Cicero, A. F., Scalise, F., Avanzini, M. A., Tinelli, C., Piccinni, M. N., Peros, E., Geroldi, D., Fogari, E. and D'Angelo, A. (2007) Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes. 14, pp. 45-51.
15. Dollery, C. M. and Libby, P. (2006) Atherosclerosis and proteinase activation. 69, pp. 625-635.
16. European Diabetes Policy Group (1999) A desktop guide to type 2 diabetes mellitus. 16, pp. 716-730.
17. Florys, B., Gowioska, B., Urban, M. and Peczyoska, J. (2006) Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes. 12, pp. 184-189.
18. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972) Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. 18, pp. 499-502.
19. Fujimoto, N., Mouri, N., Iwata, K., Ohuchi, E., Okada, Y. and Hayakawa, T. (1993) A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. 221, pp. 91-103.
20. Fujimoto, N., Hosokawa, N., Iwata, K., Shinya, T., Okada, Y. and Hayakawa, T. (1994) A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. 231, pp. 79-88.
21. Glowin'ska-Olszewska, B. and Urban, M. (2007) Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. 56, pp. 799-805.
22. Havel, R. J., Edr, H. A. and Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. 34, pp. 1345-1353.
23. Heding, L. G. (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. 8, pp. 260-266.
24. Hirsch, J. and Batchelor, B. (1976) Adipose tissue cellularity in human obesity. 5, pp. 299-311.
25. Kahn, B. B. and Flier, J. S. (2000) Obesity and insulin resistance. 106, pp. 473-481.
26. Klose, S. and Borner, K. (1978) Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II). 15, pp. 121-130.
27. Laimer, M., Kaser, S., Kranebitter, M., Sandhofer, A., Muhlmann, G., Schwelberger, H., Weiss, H., Patsch, J. R. and Ebenbichler, C. F. (2005) Effect of pronounced weight loss on the nontraditional cardiovascular risk marker metalloproteinase-9 in middle aged morbidly obese women. 29, pp. 498-501.
28. Lijnen, H. R. (2001) Plasmin and matrix metalloproteinases in vascular remodelling. 86, pp. 324-333.
29. Lijnen, H. R., Maquoi, E., Demeulemeester, D., Van Hoef, B. and Collen, D. (2002) Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. 88, pp. 345-353.
30. Lijnen, H. R., Maquoi, E., Holvoet, P., Mertens, A., Lupu, F., Morange, P., Alessi, M. C. and Juhan-Vague, I. (2001) Adipose tissue expression of gelatinases in mouse models of obesity. 85, pp. 1111-1116.
31. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. 28, pp. 412-419.
32. Maxwell, P. R., Timms, P. M., Chandran, S. and Gordon, D. (2001) Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. 18, pp. 777-780.
33. Roberts, C. K., Won, D., Pruthi, S., Kurtovic, S., Sindhu, R. K., Vaziri, N. D. and Barnard, R. J. (2006) Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. 100, pp. 1657-1665.
34. Scanu, A. M. and Scandian, L. (1991) Lipoprotein (a): Structure, biology and clinical relevance. 36, pp. 249-270.
35. Sluijter, J. P., de Kleijn, D. P. and Pasterkamp, G. (2006) Vascular remodeling and protease inhibition-bench to bedside. 69, pp. 595-603.
36. Stevens, J., Cai, J., Pamuk, E. R., Williamson, D. E., Thun, M. J. and Wood, J. L. (1998) The effect of age on the association between body-mass index and mortality. 338, pp. 1-7.
37. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D. G. and Tsao, P. S. (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress. 88, pp. 1291-1298.
38. Uterman, G. and Weber, W. (1987) Protein composition of lipoprotein (a). 80, pp. 458-465.
39. Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. 92, pp. 827-839.
40. Wahlefeld, A. W. (1974) Triglycerides determination after enzymatic hydrolysis. pp. 18-31. Academic Press, New York
41. World Health Organization (1997) WHO, Geneva